Sodium oxybate, a drug used to treat narcolepsy, may improve excessive daytime sleep and sleep disturbances in patients with Parkinson disease.
Veronica Hackethal, MD
These technologies show promise in predicting dementia years before clinical symptoms develop; diagnosing concussion and other brain injuries; and more.
There has been long-running controversy regarding the association between statins and PD risk. Two studies with conflicting results are examined here.
Findings from a new meta-analysis suggest these medications may be most effective in improving cognition in Alzheimer disease.
Featured CMEs for neurology, neuro-ophthalmology, neuroradiology, and neurosurgery, as well as a range of other topics.
A summary of cutting-edge technology, including the world’s smallest fully implantable spinal cord neurostimulator for the treatment of chronic pain.
Tools to help users monitor and detect tinnitus, control post-stroke symptoms, improve seizure monitoring, and more.
A new study found that the diabetes drug exenatide is associated with improved and sustained off-medication motor symptoms in PD, representing a major new avenue for treating the disorder.
These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.
A study found that patients with AF who initiate therapy with standard dose dabigatran are at low risk of stroke and bleeding. Insights here.